66 institutions hold shares in Genetron Holdings Limited (GTH), with 9.89M shares held by insiders accounting for 10.83% while institutional investors hold 24.16% of the company’s shares. The shares outstanding are 29.48M, and float is at 3.20M with Short Float at 8.59%. Institutions hold 21.54% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Vivo Capital, LLC with over 6.34 million shares valued at $88.76 million. The investor’s holdings represent 7.17% of the GTH Shares outstanding. As of Dec 30, 2020, the second largest holder is Capital World Investors with 2.47 million shares valued at $34.61 million to account for 2.80% of the shares outstanding. The other top investors are Jennison Associates LLC which holds 1.77 million shares representing 2.00% and valued at over $24.79 million, while Blackrock Inc. holds 1.31% of the shares totaling 1.16 million with a market value of $16.27 million.
Genetron Holdings Limited (NASDAQ: GTH) is 66.36% higher on its value in year-to-date trading and has touched a low of $9.03 and a high of $31.54 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GTH stock was last observed hovering at around $21.28 in the last trading session, with the day’s gains setting it 2.01% off its average median price target of $25.50 for the next 12 months. It is also 22.37% off the consensus price target high of $30.00 offered by 4 analysts, but current levels are 2.47% higher than the price target low of $23.88 for the same period.
Currently trading at $23.29, the stock is 7.55% and -2.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.53 million and changing 9.45% at the moment leaves the stock 47.15% off its SMA200. GTH registered a gain of 99.23% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $23.24 and a 200-day simple moving average (SMA200) of $16.93.
The stock witnessed a 14.45% loss in the last 1 month and extending the period to 3 months gives it a 69.88%, and is 20.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.06% over the week and 9.15% over the month.
Genetron Holdings Limited (GTH) has around 663 employees, a market worth around $1.95B and $64.80M in sales. Distance from 52-week low is 157.92% and -26.16% from its 52-week high. The company has generated returns on investments over the last 12 months (-77.50%).
Genetron Holdings Limited (GTH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Genetron Holdings Limited (GTH) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Genetron Holdings Limited is expected to release its quarterly report on 08/12/2021 and quarterly earnings per share for the current quarter are estimated at -$0.18 with sales reaching $14.01M over the same period.The EPS is expected to shrink by -32.40% this year, but quarterly earnings will post 47.50% year-over-year.